Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hiring
Biotech
Teva loses R&D head amid innovation revamp—Chutes & Ladders
Teva's R&D chief hangs up hat. White House pulls FDA chief nomination. Quanterix restarts search for CEO. And more.
Donavyn Coffey
,
Marissa Russo
Nov 20, 2026 8:30am
BMS unites R&D as chief of research departs—Chutes & Ladders
Nov 13, 2026 8:30am
Novo saying goodbye to longtime finance chief—Chutes & Ladders
Nov 6, 2026 10:12am
Lilly International's Patrik Jonsson to retire—Chutes & Ladders
Oct 30, 2026 8:30am
GSK's Waterhouse tapped to helm struggling CSL—Chutes & Ladders
Oct 23, 2026 8:30am
Bausch + Lomb CEO heads for exit once more—Chutes & Ladders
Oct 16, 2026 8:30am